Soleno Therapeutics

+$0.0316 (+10.22%) Today
-$0.0209 (-6.13%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLNO and other ETFs, options, and stocks.

About SLNO

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The firm focuses on the treatment of metabolic and neurobehavioral disorder.

CEO
Anish Bhatnagar
Employees
31
Headquarters
Redwood City, California
Founded
1999

SLNO Key Statistics

Market cap
27.21M
Price-Earnings ratio
—
Dividend yield
—
Average volume
266.23K
High today
$0.3483
Low today
$0.30
Open price
$0.30
Volume
244.53K
52 Week high
$3.36
52 Week low
$0.2722

SLNO Earnings

-$0.16
-$0.11
-$0.05
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Mar 2, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure